The 75 direct sales force dedicated to boost Stryker’s (NYSE: SYK) foot and ankle business unit had a stellar year in 2012, said CEO Kevin Lobo, to a packed room at the J.P. Morgan Healthcare Conference in San Francisco on Wednesday.
The unit had a 40 percent increase in U.S. sales in the fourth quarter.
“If you think about Stryker, we were just above the ‘other’ category in the foot and ankle business a few years ago,” Lobo said. “Based on Q4 and I haven’t seen Wright Medical’s numbers yet, we are breathing down their necks.”
With the Rise of AI, What IP Disputes in Healthcare Are Likely to Emerge?
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
The unit is a relatively new addition to Stryker’s business units. Lobo said it took a few quarters in the beginning of 2012 to “find our feet” (no pun intended), but in retrospect, it was a smart decision to create a dedicated sales team for the unit.
Now the company has been able to hire sales people away from market leaders like Wright Medical and Arthrex.
“The idea that a sport medicine sales person would come from Wright Medical and Arthrex a few years ago would have been laughable,” Lobo declared.
Photo Credit: Boxer fron BigStock Photo]